Schmidt BZ, Lehmann M, Gutbier S, Nembo E, Noel S, Smirnova L, Forsby A, Hescheler J, Avci HX, Hartung T, Leist M, Kobolák J, Dinnyés A. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Arch Toxicol. 2017 Jan;91(1):1-33. doi: 10.1007/s00204-016-1805-9. Epub 2016 Aug 4. Review. PubMed PMID: 27492622
Choi YS, Lee MC, Kim HS, Lee KH, Park YG, Kim HK, Jeong HS, Kim MK, Woo YJ, Kim SU, Ryu JK, Choi HB. Neurotoxicity screening in a multipotent neural stem cell line established from the mouse brain. J Korean Med Sci. 2010 Mar;25(3):440-8. doi: 10.3346/jkms.2010.25.3.440. Epub 2010 Feb 17. PubMed PMID: 20191045
the mentioned cell lines are neuroblastoma cell lines. What is your objective in availing neurotoxicity? The tumor behavior of neuroblastoma is completely different of primary neurons. Are investigating an aspect of antineoplastic drugs in neuroblastoma or other potential candidate substances, or really going for neurotoxicity in the healthy brain using primary neurons?